SCHEMBL3107378

SCHEMBL3107378

CCCCCCCCCCCCN(CCCc1ccccc1)[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.56
SIGMAR1 Q99720 4/20 0.50
OPRM1 P35372 2/20 0.47
DRD3 P35462 2/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
CHRM1 P11229 1/20 0.47
DRD1 P21728 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A4 P31645 1/20 0.47
ADRA1A P35348 1/20 0.47
SLC6A3 Q01959 1/20 0.47
DRD2 P14416 1/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
THRA P10827 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28291496 0.84 KCNH2 (0.44) KCNH2SIGMAR1CA12CA1CA2
SCHEMBL3918807 0.80 KCNH2 (0.57) KCNH2SIGMAR1CHRM2ADRA2ACHRM1
SCHEMBL612929 0.79 KCNH2 (0.80) KCNH2SIGMAR1OPRM1DRD3CHRM2
SCHEMBL7164431 0.79 KCNH2 (0.80) KCNH2SIGMAR1OPRM1DRD3CHRM2
SCHEMBL437110 0.78 ALDH1A1 (0.46) KCNH2CA12CA1CA2THRB
SCHEMBL11131202 0.77 SIGMAR1 (0.82) KCNH2SIGMAR1OPRM1DRD3CHRM2
SCHEMBL29107028 0.77 SIGMAR1 (0.82) KCNH2SIGMAR1OPRM1DRD3CHRM2
Hydrochloric Acid SCHEMBL25413352 0.76 SIGMAR1 (0.79) KCNH2SIGMAR1OPRM1DRD3CHRM2
Hydrochloric Acid SCHEMBL25414940 0.76 SIGMAR1 (0.79) KCNH2SIGMAR1OPRM1DRD3CHRM2
Hydrochloric Acid SCHEMBL25415731 0.76 SIGMAR1 (0.79) KCNH2SIGMAR1OPRM1DRD3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946302-B2 Selective sigma-1 receptor ligands WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-02-03 US disclosed
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-04-25 US disclosed
US-8349898-B2 Sigma-1 receptor ligands and methods of use WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-01-08 US disclosed
US-20100179111-A1 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE WARF - WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179111-A1 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE SIGMAR1, OPRL1, OPRK1 KCNH2 2763/4885SIGMAR1 1/4885OPRM1 4/4885
US-20130102571-A1 SELECTIVE SIGMA-1 RECEPTOR LIGANDS SIGMAR1, OPRL1, OPRK1 KCNH2 2802/4885SIGMAR1 1/4885OPRM1 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.